KRAS and neoplasm: In a study aimed at targeting KRAS in lung cancer, HEK293T cells were programmed to simultaneously express KRAS siRNA and Lamp2b, an exosomal membrane protein, coupled with a tumor-homing internalizing RGD (iRGD) peptide (Zhou et al., 2019).